High-resolution array-CGH and expression profiling identifies a novel genomic subtype of ER negative breast cancer
暂无分享,去创建一个
Y. Wang | I. O. Ellis | S. Tavare | J. D. Brenton | S. Tavaré | J. Marioni | I. Ellis | S. Chin | C. Caldas | J. Brenton | A. Teschendorff | N. Barbosa-Morais | B. Ylstra | S. Pinder | A. Green | Y. Wang | M. A. Wiel | J. Costa | N. | C. Caldas | A. R. Green | S. F. Chin | A. E. Teschendorff | J. C. Marioni | N. L. Barbosa-Morais | P. Thorne | J. Costa | S. E. Pinder | M. A. van de Wiel | L. P. | Porter | B. Ylstra | L. P. | P. Thorne
[1] Kenny Q. Ye,et al. Novel patterns of genome rearrangement and their association with survival in breast cancer. , 2006, Genome research.
[2] L. Chin,et al. High-resolution characterization of the pancreatic adenocarcinoma genome , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[3] Yudong D. He,et al. Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.
[4] V. P. Collins,et al. Differential expression of selected histone modifier genes in human solid cancers , 2006, BMC Genomics.
[5] I. Ellis,et al. A gene-expression signature to predict survival in breast cancer across independent data sets , 2007, Oncogene.
[6] Carlos Caldas,et al. Mutations truncating the EP300 acetylase in human cancers , 2000, Nature Genetics.
[7] Joanna M. Sasin,et al. Protein Tyrosine Phosphatases in the Human Genome , 2004, Cell.
[8] Céline Rouveirol,et al. Bioinformatics Original Paper Computation of Recurrent Minimal Genomic Alterations from Array-cgh Data , 2022 .
[9] S. Chin,et al. Human and mouse oligonucleotide-based array CGH , 2005, Nucleic acids research.
[10] R. Hruban,et al. Alterations in pancreatic, biliary, and breast carcinomas support MKK4 as a genetically targeted tumor suppressor gene. , 1998, Cancer research.
[11] Van,et al. A gene-expression signature as a predictor of survival in breast cancer. , 2002, The New England journal of medicine.
[12] Gordon K. Smyth,et al. limma: Linear Models for Microarray Data , 2005 .
[13] A. Nobel,et al. The molecular portraits of breast tumors are conserved across microarray platforms , 2006, BMC Genomics.
[14] T. Hunter,et al. The Protein Kinase Complement of the Human Genome , 2002, Science.
[15] D. Conrad,et al. Global variation in copy number in the human genome , 2006, Nature.
[16] M. West,et al. Gene expression predictors of breast cancer outcomes , 2003, The Lancet.
[17] Bing Zhang,et al. GOTree Machine (GOTM): a web-based platform for interpreting sets of interesting genes using Gene Ontology hierarchies , 2004, BMC Bioinformatics.
[18] Christian A. Rees,et al. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[19] Wonshik Han,et al. Genomic alterations identified by array comparative genomic hybridization as prognostic markers in tamoxifen-treated estrogen receptor-positive breast cancer , 2006, BMC Cancer.
[20] C Caldas,et al. Using array-comparative genomic hybridization to define molecular portraits of primary breast cancers , 2007, Oncogene.
[21] Z. Szallasi,et al. A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers , 2006, Nature Genetics.
[22] K. Aldape,et al. Integrated array-comparative genomic hybridization and expression array profiles identify clinically relevant molecular subtypes of glioblastoma. , 2005, Cancer research.
[23] L. Chin,et al. High-resolution genomic profiles of human lung cancer. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[24] I. Ellis,et al. A 1 Mb minimal amplicon at 8p11–12 in breast cancer identifies new candidate oncogenes , 2005, Oncogene.
[25] Philip M. Long,et al. Breast cancer classification and prognosis based on gene expression profiles from a population-based study , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[26] C. Hellberg,et al. Protein-tyrosine phosphatases and cancer , 2006, Nature Reviews Cancer.
[27] M. J. van de Vijver,et al. Gene expression profiling in breast cancer: understanding the molecular basis of histologic grade to improve prognosis. , 2006, Journal of the National Cancer Institute.
[28] Pablo Tamayo,et al. Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[29] C. Caldas,et al. Mutation analysis of CBP and PCAF reveals rare inactivating mutations in cancer cell lines but not in primary tumours , 2002, British Journal of Cancer.
[30] Hidetoshi Shimodaira,et al. Pvclust: an R package for assessing the uncertainty in hierarchical clustering , 2006, Bioinform..
[31] Joel Greshock,et al. High resolution genomic analysis of sporadic breast cancer using array-based comparative genomic hybridization , 2005, Breast Cancer Research.
[32] I. Ellis,et al. An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer , 2007, Genome Biology.
[33] J. Foekens,et al. Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer , 2005, The Lancet.
[34] M. Wigler,et al. Circular binary segmentation for the analysis of array-based DNA copy number data. , 2004, Biostatistics.
[35] John D. Storey,et al. Statistical significance for genomewide studies , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[36] I. Ellis,et al. A consensus prognostic gene expression classifier for ER positive breast cancer , 2006, Genome Biology.
[37] Christian A. Rees,et al. Molecular portraits of human breast tumours , 2000, Nature.
[38] R. Tibshirani,et al. Repeated observation of breast tumor subtypes in independent gene expression data sets , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[39] F. Speleman,et al. GAB2 is a novel target of 11q amplification in AML/MDS , 2006, Genes, chromosomes & cancer.
[40] Jane Fridlyand,et al. Bioinformatics Original Paper a Comparison Study: Applying Segmentation to Array Cgh Data for Downstream Analyses , 2022 .
[41] Ajay N. Jain,et al. Breast tumor copy number aberration phenotypes and genomic instability , 2006, BMC Cancer.
[42] Ajay N. Jain,et al. Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. , 2006, Cancer cell.
[43] R. Tibshirani,et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[44] Olivier Poch,et al. A new look towards BAC-based array CGH through a comprehensive comparison with oligo-based array CGH , 2007, BMC Genomics.
[45] Barbara J. Trask,et al. Array Comparative Genomic Hybridization Analysis of Genomic Alterations in Breast Cancer Subtypes , 2004, Cancer Research.
[46] L. Chin,et al. High-resolution genomic profiles define distinct clinico-pathogenetic subgroups of multiple myeloma patients. , 2006, Cancer cell.
[47] G. Parmigiani,et al. The Consensus Coding Sequences of Human Breast and Colorectal Cancers , 2006, Science.
[48] Luke Hughes-Davies,et al. EMSY Links the BRCA2 Pathway to Sporadic Breast and Ovarian Cancer , 2003, Cell.
[49] Robert Tibshirani,et al. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene‐expression subtypes of breast cancer , 2006, Genes, chromosomes & cancer.
[50] Eytan Domany,et al. Relationship of gene expression and chromosomal abnormalities in colorectal cancer. , 2006, Cancer research.